BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5988706)

  • 1. [The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
    Colucci CF
    Schweiz Med Wochenschr; 1966 May; 96(20):660-5. PubMed ID: 5988706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F; Dechavannes M; Fiere D
    Lyon Med; 1966 Jan; 215(1):29-35. PubMed ID: 5904663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current treatment of the edematous ascitic syndrome in alcoholic liver cirrhosis].
    Savoye B; Gayet C
    J Med Lyon; 1969 Dec; 50(177):1831-41. PubMed ID: 5374238
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA; Qureshi UF; Humayoun MA; Waseem T; Akram J
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):184-8. PubMed ID: 21183857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G; Tsianos EV
    Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 7. High doses of spironolactone in the treatment of liver cirrhosis with ascites.
    Papadoyanakis N; Darsinos J; Alexandrou K; Karli J
    Br J Clin Pract; 1972 Jan; 26(1):27-32. PubMed ID: 5025912
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of cirrhosis with ascites by corticoids].
    Vesin
    Clinique (Paris); 1965 Oct; 60(612):647-8. PubMed ID: 5858996
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE CURRENT TREATMENT OF CIRRHOTIC ASCITES].
    CONTE M
    Presse Med (1893); 1964 Jun; 72():1725-8. PubMed ID: 14154051
    [No Abstract]   [Full Text] [Related]  

  • 10. [The action of glucocorticoids and saluretics on the glomerular filtration and plasma volume in ascitic cirrhosis].
    Vesin P; Traverso H; Roberti A
    Schweiz Med Wochenschr; 1965 Aug; 95(35):1157-60. PubMed ID: 5843807
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M; Portmann B
    Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E
    Minerva Med; 1963 Oct; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
    Ginès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F;
    Aliment Pharmacol Ther; 2010 Apr; 31(8):834-45. PubMed ID: 20102356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A; Demirian H; Ionitã C; Georgescu D; Tarachiu A; Anghel R; Rubingher L
    Med Interna (Bucur); 1968 May; 20(5):523-30. PubMed ID: 5735425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Triamterene in the treatment of liver cirrhosis with ascites].
    Rodes J; Bosch J; Arroyo V; Nicolau I; Teres J; Bruguera M
    Rev Clin Esp; 1972 Dec; 127(6):1101-8. PubMed ID: 4663288
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 19. THE MANAGEMENT OF ASCITES.
    SMITH AN; MCMANUS J
    Rev Surg; 1964; 21():1-16. PubMed ID: 14106700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.